DocuSign Inc. leadership misled investors about how the pandemic’s later stages affected demand for the company’s products, a new shareholder derivative suit alleges in federal court in Delaware.
Board members at the cloud-based software company, which enables people to electronically sign legal documents, “repeatedly” told investors it would “experience sustained growth in demand for its software even after COVID-19 pandemic restrictions were lifted,” the complaint says.
But those “assurances proved to be false,” according to the complaint filed in the US District Court for the District of Delaware.
“This case copies from allegations in the securities class action filed late ...